Four versus six cycles of docetaxel and cyclophosphamide in early breast cancer.

被引：1
|
作者：
Basu, Aparna
Dabak, Vrushali S.
Loutfi, Randa
Ali, Haythem Y.
Mohammed, Hadi
Mahmood, Sharmeen
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
[2] Henry Ford Hosp, West Bloomfield, MI USA
[3] Henry Ford Hlth Syst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e12047
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12047
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Four versus six cycles of docetaxel and cyclophosphamide (TC) in early stage hormone positive breast cancer
    Basu, Aparna
    Dabak, Vrushali S.
    Loutfi, Randa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Comparison of four cycles epirubicin and cyclophosphamide (EC) followed by four cycles docetaxel (T) versus six cycles docetaxel and carboplatin (TP) as adjuvant chemotherapy for women with operable triple negative breast cancer.
    Yuan, Peng
    Du, Feng
    Wang, Jiayu
    Ma, Fei
    Fan, Ying
    Xu, Binghe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer
    Nitz, Ulrike
    Gluz, Oleg
    Clemens, Michael
    Malter, Wolfram
    Reimer, Toralf
    Nuding, Benno
    Aktas, Bahriye
    Stefek, Andrea
    Pollmanns, Anke
    Lorenz-Salehi, Fatemeh
    Uleer, Christoph
    Krabisch, Petra
    Kuemmel, Sherko
    Liedtke, Cornelia
    Shak, Steven
    Wuerstlein, Rachel
    Christgen, Matthias
    Kates, Ronald E.
    Kreipe, Hans H.
    Harbeck, Nadia
    Ackermann, S.
    Aktas, B.
    Augustin, D.
    Baake, G.
    Baumann, K.
    Berger, R.
    Bettscheider, J.
    Bischoff, J.
    Clemens, M.
    Deryal, M.
    Dubbers, H.
    Duchting, D.
    Dunnebacke, J.
    Fett, W.
    Fietz, T.
    Fischer, H.
    Forner, M.
    Forstbauer, H.
    Freese, K.
    Geberth, M.
    Glados, M.
    Gnauert, K.
    Goette, O.
    Gohring, U.
    Goppinger, A.
    Grafe, A.
    Hackenberg, R.
    Hackmann, J.
    Hellriegel, M.
    Heyl, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (10) : 799 - +
  • [4] Four vs six cycles of docetaxel and cyclophosphamide (TC) in early stage triple-negative breast cancer
    Basu, Aparna
    Mohammed, Hadi A.
    Mahmood, Sharmeen
    Dabak, Vrushali
    Loutfi, Randa
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [5] Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer.
    Santos, F. N.
    Cruz, M. R.
    Cezana, L.
    Costa, L. A.
    de Azevedo, C. A.
    De Barros, M. J.
    Silva, E.
    Cozario, L. L.
    Alencar, A. M., Jr.
    Fanelli, M. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Comparison of overall and recurrence-free survival between four and six cycles of adjuvant docetaxel and cyclophosphamide in early stage breast cancer
    Mehmi, I.
    Wight, C. E.
    Hill, J. L.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [7] DBCG 07-READ: A randomized phase III trial comparing six cycles of docetaxel and cyclophosphamide (DC) to three cycles of epirubicin and cyclophosphamide followed by three cycles of docetaxel (EC-D) in patients with early breast cancer
    Ejlertsen, B.
    Tuxen, M. K.
    Jakobsen, E. H.
    Jensen, M-B
    Knoop, A. S.
    Hoejris, I.
    Ewertz, M.
    Balslev, E.
    Vestlev, P. M.
    Kenholm, J.
    Nielsen, D. L.
    Bechmann, T.
    Andersson, M.
    Cold, S.
    Nielsen, H. M.
    Maae, E.
    Arlsen, D. C.
    Mouridsen, H. T.
    [J]. CANCER RESEARCH, 2017, 77
  • [8] Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study
    Batra, Atul
    Hannouf, Malek B.
    Alsafar, Noura
    Lupichuk, Sasha
    [J]. BREAST, 2020, 54 : 1 - 7
  • [9] Febrile neutropenia with adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer.
    Yu, Joanne Linda
    Kurin, Michael
    Pasetka, Mark
    Sridhar, Srikala S.
    Warner, Ellen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Incidence of febrile neutropenia with use of docetaxel plus cyclophosphamide (TC) for breast cancer.
    Patel, Kiran
    Diergaarde, Brenda
    Brufsky, Adam
    Jankowitz, Rachel Catherine
    Lembersky, Barry C.
    Rastogi, Priya
    Huggins-Puhalla, Shannon Leigh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345